Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

AGE inhibitor described by Kissei

June 3, 1997

Positive efficacy profile reported for Zonagen's Vasomax

May 30, 1997

Ono reports AGE inhibitors and antioxidants

May 29, 1997

Kyoto describes ACAT/lipid peroxidation inhibitors

May 29, 1997

Merck & Co. acquires majority share of Gentili

May 28, 1997

Nissan Chem. reveals new antidiabetic agents

May 28, 1997

MP-52 to be developed worldwide by HMR

May 27, 1997

Lilly describes new agents for postmenopausal syndrome

May 26, 1997

Squalene synthase inhibitors from Takeda

May 26, 1997

Celtrix receives additional U.S. patents

May 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...